ZA201304415B - Inactivated poliovaccine - Google Patents
Inactivated poliovaccineInfo
- Publication number
- ZA201304415B ZA201304415B ZA2013/04415A ZA201304415A ZA201304415B ZA 201304415 B ZA201304415 B ZA 201304415B ZA 2013/04415 A ZA2013/04415 A ZA 2013/04415A ZA 201304415 A ZA201304415 A ZA 201304415A ZA 201304415 B ZA201304415 B ZA 201304415B
- Authority
- ZA
- South Africa
- Prior art keywords
- inactivated poliovaccine
- poliovaccine
- inactivated
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
- A61K39/13—Poliovirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/125—Picornaviridae, e.g. calicivirus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5252—Virus inactivated (killed)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5254—Virus avirulent or attenuated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/525—Virus
- A61K2039/5256—Virus expressing foreign proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32621—Viruses as such, e.g. new isolates, mutants or their genomic sequences
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32634—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
- C12N2770/00011—Details
- C12N2770/32011—Picornaviridae
- C12N2770/32611—Poliovirus
- C12N2770/32661—Methods of inactivation or attenuation
- C12N2770/32662—Methods of inactivation or attenuation by genetic engineering
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
- G01N2333/005—Assays involving biological materials from specific organisms or of a specific nature from viruses
- G01N2333/08—RNA viruses
- G01N2333/085—Picornaviridae, e.g. coxsackie virus, echovirus, enterovirus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Virology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB1022077.0A GB201022077D0 (en) | 2010-12-29 | 2010-12-29 | Inactivated poliovaccine |
| PCT/GB2011/001779 WO2012090000A1 (en) | 2010-12-29 | 2011-12-29 | Inactivated poliovaccine |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA201304415B true ZA201304415B (en) | 2014-03-26 |
Family
ID=43599090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA2013/04415A ZA201304415B (en) | 2010-12-29 | 2013-06-14 | Inactivated poliovaccine |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9402892B2 (enExample) |
| EP (1) | EP2658571B1 (enExample) |
| JP (1) | JP5955860B2 (enExample) |
| CN (1) | CN103391788B (enExample) |
| AU (1) | AU2011350995B2 (enExample) |
| BR (1) | BR112013017014B1 (enExample) |
| CA (1) | CA2821859C (enExample) |
| DK (1) | DK2658571T3 (enExample) |
| ES (1) | ES2574178T3 (enExample) |
| GB (1) | GB201022077D0 (enExample) |
| RU (1) | RU2599453C2 (enExample) |
| WO (1) | WO2012090000A1 (enExample) |
| ZA (1) | ZA201304415B (enExample) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0615933D0 (en) | 2006-08-10 | 2006-09-20 | Nat Inst Biological Standards & Control | Attenuated polioviruses |
| JP6591461B2 (ja) * | 2014-06-17 | 2019-10-16 | ヤンセン ファッシンズ アンド プリベンション ベーフェーＪａｎｓｓｅｎ Ｖａｃｃｉｎｅｓ ＆ Ｐｒｅｖｅｎｔｉｏｎ Ｂ．Ｖ． | 低温適応性ウイルス弱毒化（ｃａｖａ）および新規の弱毒化ポリオウイルス株 |
| GB201700825D0 (en) * | 2017-01-17 | 2017-03-01 | Sec Dep For Health | Poliovaccine |
| CN112312925B (zh) * | 2018-03-30 | 2024-09-17 | 生物模仿公司 | 辐照灭活的脊髓灰质炎病毒、包含其的组合物及制备方法 |
| WO2020075197A1 (en) * | 2018-10-10 | 2020-04-16 | Biological E Limited | Inactivated poliomyelitis vaccine composition |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8901094D0 (en) | 1989-01-18 | 1989-03-15 | Almond Jeffrey W | Attenuated viruses |
| RU2215035C2 (ru) * | 1991-12-06 | 2003-10-27 | Уайтхэд институт фор биомедикл рисерч | Рекомбинантный полиовирусный вектор (варианты), способ его получения (варианты), способ индукции иммунного ответа у индивидуума (варианты), способ получения белка (варианты), вакцинная композиция для терапии или профилактики инфекционных заболеваний (варианты) |
| GB9705669D0 (en) | 1997-03-19 | 1997-05-07 | British Tech Group | Attenuated polioviruses |
| GB9817082D0 (en) * | 1998-08-06 | 1998-10-07 | Btg Int Ltd | Attenuated poliovirus vaccine |
| GB0615933D0 (en) * | 2006-08-10 | 2006-09-20 | Nat Inst Biological Standards & Control | Attenuated polioviruses |
-
2010
- 2010-12-29 GB GBGB1022077.0A patent/GB201022077D0/en not_active Ceased
-
2011
- 2011-12-29 ES ES11807966.4T patent/ES2574178T3/es active Active
- 2011-12-29 US US13/977,399 patent/US9402892B2/en active Active
- 2011-12-29 WO PCT/GB2011/001779 patent/WO2012090000A1/en not_active Ceased
- 2011-12-29 AU AU2011350995A patent/AU2011350995B2/en active Active
- 2011-12-29 JP JP2013546763A patent/JP5955860B2/ja active Active
- 2011-12-29 BR BR112013017014-0A patent/BR112013017014B1/pt active IP Right Grant
- 2011-12-29 RU RU2013135290/10A patent/RU2599453C2/ru active
- 2011-12-29 EP EP11807966.4A patent/EP2658571B1/en active Active
- 2011-12-29 CA CA2821859A patent/CA2821859C/en active Active
- 2011-12-29 CN CN201180063532.4A patent/CN103391788B/zh active Active
- 2011-12-29 DK DK11807966.4T patent/DK2658571T3/en active
-
2013
- 2013-06-14 ZA ZA2013/04415A patent/ZA201304415B/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2011350995B2 (en) | 2016-11-24 |
| RU2013135290A (ru) | 2015-02-10 |
| EP2658571A1 (en) | 2013-11-06 |
| US20130344108A1 (en) | 2013-12-26 |
| RU2599453C2 (ru) | 2016-10-10 |
| BR112013017014B1 (pt) | 2020-12-15 |
| CA2821859C (en) | 2020-07-07 |
| WO2012090000A1 (en) | 2012-07-05 |
| BR112013017014A2 (pt) | 2016-10-25 |
| JP2014502508A (ja) | 2014-02-03 |
| JP5955860B2 (ja) | 2016-07-20 |
| CN103391788B (zh) | 2016-04-20 |
| EP2658571B1 (en) | 2016-03-02 |
| AU2011350995A8 (en) | 2013-07-18 |
| CA2821859A1 (en) | 2012-07-05 |
| US9402892B2 (en) | 2016-08-02 |
| GB201022077D0 (en) | 2011-02-02 |
| ES2574178T3 (es) | 2016-06-15 |
| DK2658571T3 (en) | 2016-05-17 |
| CN103391788A (zh) | 2013-11-13 |
| AU2011350995A1 (en) | 2013-07-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AP3107A (en) | 5-Alkynyl-pyrimidines | |
| GB201008513D0 (en) | Adaptahaus | |
| GB201010016D0 (en) | Armacat | |
| GB201001385D0 (en) | Cable-tidies | |
| GB201001546D0 (en) | Knocktop | |
| SG10201508549UA (en) | Modified tamavidin | |
| GB201007875D0 (en) | Carabanga | |
| GB201005693D0 (en) | Corcost-sco11 | |
| TWM402726U (en) | Yuga aid | |
| GB201010524D0 (en) | Quivertip aid | |
| GB201015140D0 (en) | Laso-HQ | |
| GB201015667D0 (en) | Sensi-spray | |
| GB201002195D0 (en) | Superswoosher | |
| GB201010329D0 (en) | Watchstrap | |
| GB201003998D0 (en) | Sackmate | |
| GB201017061D0 (en) | Bazwrap | |
| GB201003208D0 (en) | Spade-aid | |
| GB201015251D0 (en) | Fuse-fob | |
| GB201003760D0 (en) | Stringking | |
| GB201013645D0 (en) | Smart-trac | |
| GB201001102D0 (en) | Uni-barrow | |
| GB201008310D0 (en) | Mumbrella | |
| GB201002930D0 (en) | Dekfan | |
| GB201009540D0 (en) | Ezelog | |
| GB201004257D0 (en) | Esow |